Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
21.4M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
400K
-
Shares change
-
-13.3K
-
Total reported value, excl. options
-
$515K
-
Value change
-
-$17K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$1.29
Significant Holders of Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) as of Q2 2023
17 filings reported holding IMNN - Imunon, Inc. - Common stock, par value $0.01 per share as of Q2 2023.
Imunon, Inc. - Common stock, par value $0.01 per share (IMNN) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 400K shares
of 21.4M outstanding shares and own 1.87% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (122K shares), RENAISSANCE TECHNOLOGIES LLC (74K shares), BlackRock Inc. (67.2K shares), CITADEL ADVISORS LLC (51.7K shares), GEODE CAPITAL MANAGEMENT, LLC (48.9K shares), STATE STREET CORP (14.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.9K shares), Tower Research Capital LLC (TRC) (8.41K shares), MORGAN STANLEY (1.63K shares), and M&R CAPITAL MANAGEMENT INC (333 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.